Madrigal Pharmaceuticals
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$20Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
21,587clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Sushama Scalera | Salem, MA | Emergency Medicine | $613,288.00 |
| Mazen Noureddin | Houston, TX | Gastroenterology (Internal Medicine) | $472,411.67 |
| Cynthia Guy | Durham, NC | Anatomic Pathology & Clinical Pathology | $378,870.56 |
| Zahid Vahora | Washington, DC | Transplant Hepatology | $359,341.97 |
| Santiago Munoz | Toms River, NJ | Transplant Hepatology | $357,858.69 |
| Naim Alkhouri | Westlake, OH | Gastroenterology (Internal Medicine) | $336,630.84 |
| Anthony Martinez | Buffalo, NY | Internal Medicine | $231,611.97 |
| Nadege Gunn | Waco, TX | Gastroenterology (Internal Medicine) | $217,859.10 |
| Pierre Gholam | Cleveland, OH | Gastroenterology (Internal Medicine) | $213,963.40 |
| Julio Gutierrez | Los Angeles, CA | Transplant Hepatology | $201,983.26 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.